Recursion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Recursion (Nasdaq: RXRX) announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026.

Webcasts of the appearance will be available in the events section of the Recursion investor relations website at ir.recursion.com.

News Market Reaction – RXRX

-4.75%

3 alerts

-4.75% Session close to close

$1.83B Market Cap

0.1x Rel. Volume

In the Jun 2 session, RXRX declined 4.75%, reflecting a moderate negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Salt Lake City, UT, June 02, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically improve lives, today announced its participation in an upcoming investor conference:

• Goldman Sachs 47th Annual Global Healthcare Conference — Tuesday, June 9, 2026

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com. 
About Recursion
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI-native, end-to-end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose-built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Media Contact
media@recursion.com
Investor Contact
investor@recursion.com

Ryan Kelly
Recursion Pharmaceuticals
media@recursion.com

FAQ

When will Recursion (RXRX) present at the Goldman Sachs 47th Annual Global Healthcare Conference?

Recursion is scheduled to participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9, 2026. According to Recursion, investors can follow the company’s appearance via webcast on its investor relations website in the events section.

How can investors access the Recursion (RXRX) webcast for the June 9, 2026 Goldman Sachs healthcare conference?

Investors can access Recursion’s Goldman Sachs healthcare conference webcast through the events section of its investor relations site at ir.recursion.com. According to Recursion, the webcast link will be available there for those wishing to listen to the company’s conference participation.

Where is Recursion (RXRX) headquartered and what type of company is it?

Recursion is headquartered in Salt Lake City, Utah, and is described as a leading clinical-stage TechBio company. According to Recursion, it focuses on decoding biology with the goal of radically improving lives through its technology-enabled drug discovery efforts.

What is the significance of Recursion (RXRX) joining the Goldman Sachs 47th Annual Global Healthcare Conference?

Recursion’s participation highlights its inclusion among healthcare companies presenting to institutional investors at a major Goldman Sachs event. According to Recursion, investors can learn more about its clinical-stage TechBio strategy and progress by listening to the webcast available on its investor relations website.

On which stock exchange is Recursion (RXRX) listed for investors?

Recursion is listed on the Nasdaq stock exchange under the ticker symbol RXRX. According to Recursion, the company is a clinical-stage TechBio firm focused on decoding biology, giving Nasdaq investors exposure to its technology-driven approach to improving patient lives.